当前位置: 首页 > 期刊 > 《新医学》 > 20189
编号:13574492
肺动脉高压大鼠肺组织中TGFβ1和IL6的表达水平及意义(4)
http://www.100md.com 2018年9月1日 《新医学》 20189
     [7]王丹姝,方蓮花,杜冠华转化生长因子β1在肺动脉高压中作用的研究进展中国药理学通报,2017,33(6):741744

    [8]雷丰丰,张启菎,万毅新。转化生长因子β1与肺纤维化新医学,2003,34(11):715716

    [9]Li XW, Du J, Hu GY, Hu CP, Li D, Li YJ, Li XH Fluorofenidone attenuates vascular remodeling in hypoxiainduced pulmonary hypertension of ratsCan J Physiol Pharmacol,2014,92(1):5869

    [10]Hagen M, Fagan K, Steudel W, Carr M, Lane K, Rodman DM, West JInteraction of interleukin6 and the BMP pathway in pulmonary smooth muscleAm J Physiol Lung Cell Mol Physiol,2007,292(6):L1473L1479

    [11]HashimotoKataoka T, Hosen N, Sonobe T, Arita Y, Yasui T, Masaki T, Minami M, Inagaki T, Miyagawa S, Sawa Y, Murakami M, Kumanogoh A, YamauchiTakihara K, Okumura M, Kishimoto T, Komuro I, Shirai M, Sakata Y, Nakaoka YInterleukin6/interleukin21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertensionProc Natl Acad Sci U S A,2015,112(20):E2677E2686

    [12]Humbert M, Monti G, Brenot F, Sitbon O, Portier A, GrangeotKeros L, Duroux P, Galanaud P, Simonneau G, Emilie DIncreased interleukin1 and interleukin6 serum concentrations in severe primary pulmonary hypertensionAm J Respir Crit Care Med,1995,151(5):16281631, 百拇医药(邓凯 邹勇 廖志新 郑常龙)
上一页1 2 3 4